Jesse Swen
Jesse Swen
Associate Professor of Pharmacogenetics, Leiden University Medical Center, Leiden, The Netherlands
Verified email at lumc.nl
Title
Cited by
Cited by
Year
Pharmacogenetics: from bench to byte—an update of guidelines
JJ Swen, M Nijenhuis, A de Boer, L Grandia, AH Maitland‐van der Zee, ...
Clinical Pharmacology & Therapeutics 89 (5), 662-673, 2011
9092011
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants
JK Hicks, JJ Swen, CF Thorn, K Sangkuhl, ED Kharasch, VL Ellingrod, ...
Clinical Pharmacology & Therapeutics 93 (5), 402-408, 2013
4432013
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants
JK Hicks, JJ Swen, CF Thorn, K Sangkuhl, ED Kharasch, VL Ellingrod, ...
Clinical Pharmacology & Therapeutics 93 (5), 402-408, 2013
4432013
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP3A5 genotype and tacrolimus dosing
KA Birdwell, B Decker, JM Barbarino, JF Peterson, CM Stein, W Sadee, ...
Clinical Pharmacology & Therapeutics 98 (1), 19-24, 2015
3312015
Clinical Pharmacogenetics Implementation Consortium guidelines for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing
KE Caudle, CF Thorn, TE Klein, JJ Swen, HL McLeod, RB Diasio, ...
Clinical Pharmacology & Therapeutics 94 (6), 640-645, 2013
3252013
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process
K E Caudle, T E Klein, J M Hoffman, D J Muller, M Whirl-Carrillo, L Gong, ...
Current drug metabolism 15 (2), 209-217, 2014
3002014
Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
JK Hicks, K Sangkuhl, JJ Swen, VL Ellingrod, DJ Müller, K Shimoda, ...
Clinical Pharmacology & Therapeutics 102 (1), 37-44, 2017
2832017
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update
U Amstutz, LM Henricks, SM Offer, J Barbarino, JHM Schellens, JJ Swen, ...
Clinical Pharmacology & Therapeutics 103 (2), 210-216, 2018
2122018
Pharmacogenetics: from bench to byte
JJ Swen, I Wilting, AL De Goede, L Grandia, H Mulder, DJ Touw, ...
Clinical Pharmacology & Therapeutics 83 (5), 781-787, 2008
2102008
Translating pharmacogenomics: challenges on the road to the clinic
JJ Swen, TW Huizinga, H Gelderblom, EGE De Vries, WJJ Assendelft, ...
PLoS Med 4 (8), e209, 2007
2082007
Implementing pharmacogenomics in Europe: design and implementation strategy of the ubiquitous pharmacogenomics consortium
CH van der Wouden, A Cambon‐Thomsen, E Cecchin, KC Cheung, ...
Clinical Pharmacology & Therapeutics 101 (3), 341-358, 2017
1542017
Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization
J Kevin Hicks, J J Swen, A Gaedigk
Current drug metabolism 15 (2), 218-232, 2014
1502014
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis
LM Henricks, CATC Lunenburg, FM de Man, D Meulendijks, ...
The Lancet Oncology 19 (11), 1459-1467, 2018
1342018
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and …
KE Caudle, K Sangkuhl, M Whirl‐Carrillo, JJ Swen, CE Haidar, TE Klein, ...
Clinical and translational science 13 (1), 116-124, 2020
1242020
Comparison of the guidelines of the clinical pharmacogenetics implementation consortium and the dutch pharmacogenetics working group
PCD Bank, KE Caudle, JJ Swen, RS Gammal, M Whirl‐Carrillo, TE Klein, ...
Clinical Pharmacology & Therapeutics 103 (4), 599-618, 2018
1182018
Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: ready for prime time
CATC Lunenburg, LM Henricks, HJ Guchelaar, JJ Swen, MJ Deenen, ...
European Journal of Cancer 54, 40-48, 2016
852016
Effect of CYP3A4* 22, CYP3A5* 3, and CYP3A combined genotypes on cyclosporine, everolimus, and tacrolimus pharmacokinetics in renal transplantation
D Moes, JJ Swen, J Den Hartigh, T Van Der Straaten, JJH van der Heide, ...
CPT: pharmacometrics & systems pharmacology 3 (2), 1-12, 2014
782014
Translating DPYD genotype into DPD phenotype: using the DPYD gene activity score
LM Henricks, CATC Lunenburg, D Meulendijks, H Gelderblom, A Cats, ...
Pharmacogenomics 16 (11), 1275-1284, 2015
772015
Association analysis of genetic polymorphisms in genes related to sunitinib pharmacokinetics, specifically clearance of sunitinib and SU12662
MHM Diekstra, HJ Klümpen, M Lolkema, H Yu, JSL Kloth, H Gelderblom, ...
Clinical Pharmacology & Therapeutics 96 (1), 81-89, 2014
742014
Association analysis of genetic polymorphisms in genes related to sunitinib pharmacokinetics, specifically clearance of sunitinib and SU12662
MHM Diekstra, HJ Klümpen, M Lolkema, H Yu, JSL Kloth, H Gelderblom, ...
Clinical Pharmacology & Therapeutics 96 (1), 81-89, 2014
742014
The system can't perform the operation now. Try again later.
Articles 1–20